Navigation Links
Niche Pharmaceuticals, Inc. Asks "Are You Ready to Get Your Life Back from Chronic Migraines?"
Date:12/9/2015

SOUTHLAKE, Texas, Dec. 9, 2015 /PRNewswire/ -- Niche Pharmaceuticals, Inc. has launched a microsite (www.MagnesiumRoadtoMigrainePrevention.com) which features an overview of the research done on the link between magnesium deficiency and chronic migraine headaches. Niche Pharmaceuticals invites people with chronic migraine headaches to explore the site to better understand findings on the connection between low magnesium and migraine headaches.

Published clinical trials (1) have shown that daily magnesium supplementation taken for a minimum of two to three months can reduce the occurrence of migraine days by at least fifty percent. Results will vary per individual. In fact, the American Headache Society and the American Academy of Neurology now include oral magnesium in their preventive treatment guidelines for migraines (2). There is strong evidence that magnesium deficiency is much more prevalent in those with chronic migraine headaches than in healthy controls. 

Mag-Tab®SR is Niche's magnesium product that has a unique formulation that delivers magnesium L-lactate dihydrate into the body slowly for maximum absorption. Taken daily, Mag-Tab®SR provides twenty-four hours of continuous magnesium supplementation. The slow release component leads to better uptake in the body's cells and relief of many symptoms associated with magnesium deficiency. 

According to the company's founder and CEO, Steve F. Brandon, studies show(3) approximately four out of five people in the United States do not get enough magnesium in their diet and may be magnesium deficient. Up to fifty percent of the thirty-six million American migraine sufferers have low magnesium levels associated with their chronic migraines (4). This is especially true for women (5). Doctors recommend non-prescription Mag-Tab®SR because it is a sustained release magnesium supplement that is highly absorbed and well-tolerated by the gastrointestinal tract(6).

A "Migraine Prevention" pack with two bottles of one hundred caplets and a free sixty count bottle are available as part of the campaign and can be purchased at http://www.magnesiumroadtomigraineprevention.com. The pack contains two months' worth of daily magnesium intake and participants will receive a discount code for their next purchase at magtabsr.com, the company's website. Migraineurs are invited to share their progress and results on Mag-Tab® SR's Facebook page (www.facebook.com/magtabsr), tweet to @magtabsr, and use the mobile migraine tracking app Migraine Buddy where a Mag-Tab®SR group has been created.

About Niche Pharmaceuticals, Inc.
Niche Pharmaceuticals, Inc. was founded in 1991 to develop and market ethical pharmaceutical grade nutraceutical products that fulfill unmet medical needs. Over the years, Niche has a developed a reputable base of U.S. and International doctors who recommend Mag-Tab®SR, a non-prescription magnesium supplement. Niche has also dedicated considerable financial resources towards developing the first Rx oral magnesium product for the prevention of migraine headaches with major clinical trials now underway across the US.

Media Contact:
Steve Brandon 
Niche Pharmaceuticals, Inc. 
580 Commerce St, Ste. 100 
Southlake, Texas 76092 
800-677-0355
817-421-2777
www.magnesiumroadtomigraineprevention.com
www.magtabsr.com 
info@magtabsr.com

Citations

(1) http://www.ncbi.nlm.nih.gov/pubmed/18705538

(2) http://tools.aan.com/professionals/practice/pdfs/gl0090.pdf

(3) http://www.foxnews.com/health/2013/11/23/7-nutrients-lacking-in-your-diet.html

(4) https://migraine.com/pro/migraine-prevalence-and-incidence/

(5) https://migraine.com/pro/migraine-prevalence-and-incidence/

(6) http://www.magtabsr.com/template/pdf/Bioavailability-and-Pharmacokinetics-of-Mg-After-Admin-of-Mg-Salts-in-Humans.pdf

 

Photo - http://photos.prnewswire.com/prnh/20151207/293835
Photo - http://photos.prnewswire.com/prnh/20151207/293836

 


'/>"/>
SOURCE Niche Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets
2. Percutaneous Coronary Intervention Devices: Niche Opportunities Emerge in Western Europe
3. Global Gelatin and Gelatin Derivatives Isinglass and Bone Glues Market in Europe 2014-2018: Key Vendors are AB Vickers, Corngroup, Fritz Hacker GmbH & Co, Gelita, Kerry Ingredients and Flavours and Menichetti
4. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
5. KaloBios Pharmaceuticals, Inc. Raises $8.2 Million in Private Placement
6. KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing
7. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2015
8. Ground Zero Pharmaceuticals, Inc. (GZP) Announces New Additions, Services for its Global Clients
9. Global Hyperphosphatemia Drugs Market 2015-2019 with Fresenius Medical Care, Keryx Biopharmaceuticals, Sanofi, Shire & Vifor Pharma Dominating
10. ContraVir Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock And Warrants
11. Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality ... Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early ... FDA scrutiny and growing demands to track and report adverse events place even ...
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... ... “A Short Walk to the Mailbox”: a remarkable memoir of an unconventional ... Ed Clark. Ed Clark is a church music director and choral conductor. ... music and worship leader for over fifty years. He has a master’s degree ...
Breaking Medicine News(10 mins):